Literature DB >> 27865933

Mechanistic analysis of triamcinolone acetonide release from PLGA microspheres as a function of varying in vitro release conditions.

Amy C Doty1, Ying Zhang2, David G Weinstein3, Yan Wang4, Stephanie Choi4, Wen Qu4, Sachin Mittal5, Steven P Schwendeman6.   

Abstract

In vitro tests for controlled release PLGA microspheres in their current state often do not accurately predict in vivo performance of these products during formulation development. Here, we introduce a new mechanistic and multi-phase approach to more clearly understand in vitro-in vivo relationships, and describe the first "in vitro phase" with the model drug, triamcinolone acetonide (Tr-A). Two microsphere formulations encapsulating Tr-A were prepared from PLGAs of different molecular weights and end-capping (18kDa acid-capped and 54kDa ester-capped). In vitro release kinetics and the evidence for controlling mechanisms (i.e., erosion, diffusion, and water-mediated processes) were studied in four release media: PBST pH 7.4 (standard condition), PBST pH 6.5, PBS+1.0% triethyl citrate (TC), and HBST pH 7.4. The release mechanism in PBST was primarily polymer erosion-controlled as indicated by the similarity of release and mass loss kinetics. Release from the low MW PLGA was accelerated at low pH due to increased rate of hydrolysis and in the presence of the plasticizer TC due to slightly increased hydrolysis and much higher diffusion in the polymer matrix. TC also increased release from the high MW PLGA due to increased hydrolysis, erosion, and diffusion. This work demonstrates how in vitro conditions can be manipulated to change not only rates of drug release from PLGA microspheres but also the mechanism(s) by which release occurs. Follow-on studies in the next phases of this approach will utilize these results to compare the mechanistic data of the Tr-A/PLGA microsphere formulations developed here after recovery of microspheres in vivo. This new approach based on measuring mechanistic indicators of release in vitro and in vivo has the potential to design better, more predictive in vitro release tests for these formulations and potentially lead to mechanism-based in vitro-in vivo correlations.
Copyright © 2016. Published by Elsevier B.V.

Entities:  

Keywords:  Formulation; In vitro; Kinetics; Mechanism; Poly(lactic-co-glycolic) acid; Release

Mesh:

Substances:

Year:  2016        PMID: 27865933     DOI: 10.1016/j.ejpb.2016.11.008

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  3 in total

1.  Evaluation of surface layer stability of surface-modified polyester biomaterials.

Authors:  Hamish Poli; Alexandra L Mutch; Anitha A; Saso Ivanovski; Cedryck Vaquette; David G Castner; María Natividad Gómez-Cerezo; Lisbeth Grøndahl
Journal:  Biointerphases       Date:  2020-12-04       Impact factor: 2.456

Review 2.  FDA's Poly (Lactic-Co-Glycolic Acid) Research Program and Regulatory Outcomes.

Authors:  Yan Wang; Bin Qin; Grace Xia; Stephanie H Choi
Journal:  AAPS J       Date:  2021-06-29       Impact factor: 4.009

Review 3.  Challenges and Complications of Poly(lactic-co-glycolic acid)-Based Long-Acting Drug Product Development.

Authors:  Yi Wen Lim; Wen Siang Tan; Kok Lian Ho; Abdul Razak Mariatulqabtiah; Noor Hayaty Abu Kasim; Noorsaadah Abd Rahman; Tin Wui Wong; Chin Fei Chee
Journal:  Pharmaceutics       Date:  2022-03-11       Impact factor: 6.321

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.